Analytical Data
-
Gene name
AMDHD1
- Application
-
Alternative Names
Amidohydrolase domain-containing protein 1
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96NU7
-
Expression Region
1-426aa
-
Molecular Weight
62.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AMDHD1 (Acyl-Modified Domain-Containing Protein 1) is a member of the acyl-activating enzyme family, which plays a crucial role in lipid metabolism and signaling pathways. Research on AMDHD1 has gained attention due to its potential implications in various biological processes and diseases, including metabolic disorders and cancer. The enzyme is involved in the acylation of specific substrates, influencing cellular functions and the regulation of signaling pathways. Recent studies have focused on elucidating its structural characteristics and enzymatic mechanisms, revealing insights into how AMDHD1 modulates lipid homeostasis and contributes to cellular signaling networks. Moreover, its dysregulation has been implicated in pathological conditions, making it a target of interest for therapeutic interventions. Understanding the functional role of AMDHD1 could pave the way for novel strategies in targeting metabolic diseases and developing potential biomarkers for cancer progression, highlighting its significance in both basic and applied biomedical research.
